NO20070146L - 4-fenylpyrimidin-2-karbonitril-derivater - Google Patents

4-fenylpyrimidin-2-karbonitril-derivater

Info

Publication number
NO20070146L
NO20070146L NO20070146A NO20070146A NO20070146L NO 20070146 L NO20070146 L NO 20070146L NO 20070146 A NO20070146 A NO 20070146A NO 20070146 A NO20070146 A NO 20070146A NO 20070146 L NO20070146 L NO 20070146L
Authority
NO
Norway
Prior art keywords
phenylpyrimidine
derivatives
carbonitrile derivatives
relates
carbonitrile
Prior art date
Application number
NO20070146A
Other languages
English (en)
Inventor
Jiaqiang Cai
Zoran Rankovic
Jennifer Helen Moir
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of NO20070146L publication Critical patent/NO20070146L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen angår 4-fenyl-pyrimidin-2-karbonitril-derivater som har den generelle formel I eller et farmasøytisk akseptabelt salt derav. Oppfinnelsen vedrører også farmasøytiske preparater omfattende de nevnte derivater, så vel som anvendelse derav ved fremstilling av et medikament egnet for behandling av osteoporose, ateroskle-rose, inflammasjon og immunlidelser, så som revmatoid artritt, og kronisk smerte, så som nevropatisk smerte.
NO20070146A 2004-06-11 2007-01-09 4-fenylpyrimidin-2-karbonitril-derivater NO20070146L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04253491 2004-06-11
EP04106949 2004-12-23
PCT/EP2005/006266 WO2005121106A1 (en) 2004-06-11 2005-06-09 4-phenyl-pyrimidine-2-carbonitrile derivatives

Publications (1)

Publication Number Publication Date
NO20070146L true NO20070146L (no) 2007-02-02

Family

ID=34972893

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070146A NO20070146L (no) 2004-06-11 2007-01-09 4-fenylpyrimidin-2-karbonitril-derivater

Country Status (26)

Country Link
US (1) US7589095B2 (no)
EP (1) EP1758870B1 (no)
JP (1) JP2008501764A (no)
KR (1) KR20070043779A (no)
CN (1) CN1980897A (no)
AR (1) AR053303A1 (no)
AT (1) ATE404542T1 (no)
AU (1) AU2005251923A1 (no)
BR (1) BRPI0511951A (no)
CA (1) CA2567845A1 (no)
DE (1) DE602005008960D1 (no)
DK (1) DK1758870T3 (no)
EC (1) ECSP067074A (no)
ES (1) ES2313380T3 (no)
IL (1) IL179444A0 (no)
MX (1) MXPA06014423A (no)
MY (1) MY140123A (no)
NO (1) NO20070146L (no)
NZ (1) NZ551772A (no)
PE (1) PE20060432A1 (no)
PL (1) PL1758870T3 (no)
PT (1) PT1758870E (no)
RS (1) RS20060662A (no)
RU (1) RU2382773C2 (no)
TW (1) TW200614993A (no)
WO (1) WO2005121106A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1901747A2 (en) * 2005-05-25 2008-03-26 Ingenium Pharmaceuticals AG Pyrimidine-based cdk inhibitors for treating pain
US8999984B2 (en) 2006-05-26 2015-04-07 University Of Louisville Research Foundation, Inc. Macrophage migration inhibitory factor antagonists and methods of using same
EP2137166B1 (en) 2007-04-24 2012-05-30 Ingenium Pharmaceuticals GmbH 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
KR100936278B1 (ko) * 2007-12-14 2010-01-13 한국생명공학연구원 단백질 포스파타제의 활성을 억제하는 피리미딘 유도체또는 이의 약학적으로 허용가능한 염을 유효성분으로함유하는 암 예방 및 치료용 조성물
AU2009208712B2 (en) * 2008-02-01 2013-03-14 Orchid Chemicals & Pharmaceuticals Limited Novel heterocycles
WO2011038234A2 (en) 2009-09-24 2011-03-31 University Of Louisville Research Foundation, Inc. Novel iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (mif)-implicated diseases and conditions
WO2011146824A1 (en) 2010-05-20 2011-11-24 University Of Louisville Research Foundation, Inc. Methods and compositions for modulating ocular damage
IN2014CN02475A (no) 2011-10-06 2015-06-19 Bayer Ip Gmbh
CA2870527A1 (en) * 2012-04-17 2013-10-24 Astellas Pharma Inc. Nitrogenated bicyclic aromatic heterocyclic compound
CN104211645B (zh) * 2014-08-12 2016-08-24 武汉珈瑜科技有限公司 嘧啶类衍生物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO890521L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte pyrimidiner.
JP2004518723A (ja) * 2001-02-14 2004-06-24 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー ピリミジンマトリックスメタロプロテイナーゼ阻害剤
AR036375A1 (es) * 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
US20030144234A1 (en) 2001-08-30 2003-07-31 Buxton Francis Paul Methods for the treatment of chronic pain and compositions therefor
GB0121033D0 (en) 2001-08-30 2001-10-24 Novartis Ag Organic compounds
SE0201976D0 (sv) * 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
SE0201980D0 (sv) 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
GB0220187D0 (en) * 2002-08-30 2002-10-09 Novartis Ag Organic compounds
US7326715B2 (en) * 2005-09-23 2008-02-05 N.V. Organon 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives

Also Published As

Publication number Publication date
NZ551772A (en) 2009-05-31
DK1758870T3 (da) 2008-10-20
HK1100002A1 (en) 2007-08-31
ATE404542T1 (de) 2008-08-15
IL179444A0 (en) 2007-05-15
KR20070043779A (ko) 2007-04-25
RS20060662A (sr) 2008-09-29
MY140123A (en) 2009-11-30
ES2313380T3 (es) 2009-03-01
DE602005008960D1 (de) 2008-09-25
JP2008501764A (ja) 2008-01-24
PT1758870E (pt) 2008-10-15
PL1758870T3 (pl) 2009-01-30
RU2382773C2 (ru) 2010-02-27
BRPI0511951A (pt) 2008-01-29
PE20060432A1 (es) 2006-06-23
EP1758870A1 (en) 2007-03-07
RU2007101161A (ru) 2008-07-20
EP1758870B1 (en) 2008-08-13
ECSP067074A (es) 2007-01-26
US20080090813A1 (en) 2008-04-17
AU2005251923A1 (en) 2005-12-22
US7589095B2 (en) 2009-09-15
MXPA06014423A (es) 2007-02-19
CN1980897A (zh) 2007-06-13
WO2005121106A1 (en) 2005-12-22
TW200614993A (en) 2006-05-16
AR053303A1 (es) 2007-05-02
CA2567845A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
NO20082791L (no) 6-fenyl-1H-imidazo[4,5-C]-pyridin-4-karbonitrilderivater som Cathepsin K- og S-inhibitorer
WO2008042688A3 (en) Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
NO20090321L (no) Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte
WO2012007868A3 (en) N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
WO2012007877A3 (en) N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
EP3363797A8 (en) Oral dosage form of apoptosis signal-regulating kinase inhibitors
NO20085100L (no) Nye forbindelser
PL2150530T3 (pl) Podstawione pochodne sulfonamidu
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
NO20082498L (no) Diarylurea for behandling av pulmonar hypertensjon
MX2010001236A (es) Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1).
NO20071594L (no) Pyrimidinsulfonamidderivater som kjemokinreseptormodulatorer
WO2012048129A3 (en) Inhibitors of polo-like kinase
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
NO20062923L (no) Nye benzofuranderivater som kan anvendes i forebygging eller behandling av 5-HT6 reseptorrelatert forstyrrelse
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2009130422A3 (fr) N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
WO2008026048A3 (en) Stable injectable pharmaceutical compositions of docetaxel
NO20075637L (no) 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitet
BRPI0512357A (pt) composições compreendendo estrÈncio e vitamina d e usos destas
ECSP067074A (es) Derivados de 4-fenil-pirimidina-2-carbonitrilo
BR0105787A (pt) Composição farmacêutica, uso de um composto farmacêutico, método para tratamento de distúrbios, composto farmacêutico e método para confeccionar um composto farmacêutico
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application